Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders

  • Frieda Matthys
  • Steven Stes
  • Wim van den Brink
  • Peter Joostens
  • David Möbius
  • Sabine Tremmery
  • Bernard Sabbe
Article

Abstract

Currently there is no guideline for the screening, diagnosis and treatment of adult attention deficit/hyperactivity disorder (ADHD) in patients with a substance use disorder (SUD). The aim was to develop such a guideline, starting out from a systematic review and based on the methodology of the Scottish Intercollegiate Guideline Network (SIGN). Due to the lack of scientific evidence on some of the topics, the guideline is a combination of evidence based and practice based recommendations. Given the high prevalence of ADHD in treatment seeking SUD patients and the availability of valid screening instruments, all treatment seeking SUD patients should be screened for ADHD. Diagnosis of ADHD should be based on clinical observation and history taking, including informant data. Integrated treatment of ADHD and SUD is recommended, including pharmacotherapy, psycho-education, coaching, and cognitive behavioral therapy (CBT). The lack of scientific data and the overall lack of expertise in the field are significant obstacles to the implementation of the guideline. Intensive training programs in the substance abuse sector need to be organized to implement these guidelines.

Keywords

Guideline Attention deficit hyperkinetic disorder Substance use disorder Comorbidity Screening Diagnosis Treatment ADHD 

References

  1. Adler, L., & Cohen, J. (2004). Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27(2), 187–201.PubMedCrossRefGoogle Scholar
  2. Adler, L. A., Faraone, S. V., Spencer, T. J., Michelson, D., Reimherr, F. W., Glatt, S. J., et al. (2008). The reliability and validity of self- and investigator ratings of ADHD in adults. Journal of Attention Disorders, 11(6), 711–719.PubMedCrossRefGoogle Scholar
  3. Adler, L., Guida, F., Irons, S., & Shaw, D. M. (2010). Open label pilot study of atomoxetine in adults with ADHD and substance use disorder. Journal of Dual Diagnosis, 6(3–4), 196–207. doi:10.1080/15504263.2010.537224.CrossRefGoogle Scholar
  4. Agreecollaboration.org. (2003). Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care, 12(1), 18–23.CrossRefGoogle Scholar
  5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Publishing.Google Scholar
  6. Arcia, E., & CONNERS, K. C. (1998). Gender differences in ADHD? Journal of Developmental & Behavioral Pediatrics, 19(2), 77–83.CrossRefGoogle Scholar
  7. Arias, A. J., Gelernter, J., Chan, G., Weiss, R. D., Brady, K. T., Farrer, L., et al. (2008). Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors, 33(9), 1199–1207.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., & Faraone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152(11), 1652–1658.PubMedGoogle Scholar
  9. Biederman, J., Wilens, T. E., Mick, E., Faraone, S. V., & Spencer, T. (1998). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44(4), 269–273.PubMedCrossRefGoogle Scholar
  10. Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Klein, K. L., et al. (2006). Psychopathology in females with attention-deficit/hyperactivity disorder: a controlled, five-year prospective study. Biological Psychiatry, 60(10), 1098–1105.PubMedCrossRefGoogle Scholar
  11. Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009). Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics, 124(1), 71–78.PubMedCrossRefPubMedCentralGoogle Scholar
  12. Bright, G. M. (2008). Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. The Medscape Journal of Medicine, 10(5), 111.PubMedCentralGoogle Scholar
  13. Carpentier, P. J., Knapen, L. J., van Gogh, M. T., Buitelaar, J. K., & De Jong, C. A. (2012). Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence. Journal of Addictive Diseases, 31(1), 45–59.PubMedCrossRefGoogle Scholar
  14. Castaneda, R., Levy, R., Hardy, M., & Trujillo, M. (2000). Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services, 51(2), 169–171.PubMedCrossRefGoogle Scholar
  15. Cebam.be. (2013). Default. [online] Retrieved from: http://www.cebam.be.
  16. Chiasson, J. P., Stavro, K., Rizkallah, E., Lapierre, L., Dussault, M., Legault, L., et al. (2012). Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations. Journal of Attention Disorders, 16(8), 661–663. doi:10.1177/1087054711425768.PubMedCrossRefGoogle Scholar
  17. Cleland, C., Magura, S., Foote, J., Rosenblum, A., & Kosanke, N. (2006). Factor structure of the Conners adult ADHD rating scale (CAARS) for substance users. Addictive Behaviors, 31(7), 1277–1282.PubMedCrossRefGoogle Scholar
  18. Culpepper, L., & Mattingly, G. (2008). A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgraduate Medicine, 120(3), 16–26.PubMedCrossRefGoogle Scholar
  19. Dakwar, E., Mahony, A., Pavlicova, M., Glass, A., Brooks, D., Mariani, J. J., et al. (2012). The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. The Journal of Clinical Psychiatry, 73(11), e1372–e1378. doi:10.4088/JCP.12m07895.PubMedCrossRefPubMedCentralGoogle Scholar
  20. Dodson, W. W. (2005). Pharmacotherapy of adult ADHD. Journal of Clinical Psychology, 61(5), 589–606.PubMedCrossRefGoogle Scholar
  21. Epstein, J.N., Johnson D.E., & C.K., C. (2001). CAADID, the Conner's Adult ADHD Diagnostic Interview for DSM-IV. Multi-Health Systems. New York: North Tonawanda.Google Scholar
  22. Faraone, S. V., & Wilens, T. (2003). Does stimulant treatment lead to substance use disorders? American Journal of Clinical Psychiatry, 64(Suppl 11), 9–13.Google Scholar
  23. Faraone, S. V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide prevalence of ADHD: is it an American condition? World Psychiatry, 2(2), 104–113.PubMedPubMedCentralGoogle Scholar
  24. Faraone, S. V., Wilens, T. E., Petty, C., Antshel, K., Spencer, T., & Biederman, J. (2007). Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. The American Journal on Addictions, 16(Suppl 1), 24–32. quiz 33–34.PubMedCrossRefGoogle Scholar
  25. Farhoodi, F., Rostami, R., Abdolmanafi, A., & Amiri, M. (2010). A study and comparison of the symptoms of attention deficit hyperactivity disorder (ADHD) among patients with substance use disorder and normal people. Procedia-Social and Behavioral Sciences, 5, 892–895.CrossRefGoogle Scholar
  26. Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., et al. (2007). Cross–national prevalence and correlates of adult attention–deficit hyperactivity disorder. The British Journal of Psychiatry, 190(5), 402–409.PubMedCrossRefGoogle Scholar
  27. Gingerich, K. J., Turnock, P., Litfin, J. K., & Rosen, L. A. (1998). Diversity and attention deficit hyperactivity disorder. Journal of Clinical Psychology, 54(4), 415–426.PubMedCrossRefGoogle Scholar
  28. Glind, G. van de, Kooij JJS, Duin, D. van, Goossensen, A., & Carpentier, PJ (2004). Protocol ADHD bij verslaving. Screening, diagnostiek en behandeling voor de ambulante en klinische verslavingszorg.Google Scholar
  29. Goossensen, M. A., van de Glind, G., Carpentier, P. J., Wijsen, R., van Duin, D., & Kooij, J. J. (2006). An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. Journal of substance abuse treatment, 30(3), 253–259.PubMedCrossRefGoogle Scholar
  30. Health.belgium.be. (2014). Fps health. [online] Retrieved from: http://www.health.belgium.be/eportal?fodnlang=en.
  31. Hesslinger, B., van Elst, L. T., Nyberg, E., Dykierek, P., Richter, H., Berner, M., et al. (2002). Psychotherapy of attention deficit hyperactivity disorder in adults. European archives of psychiatry and clinical neuroscience, 252(4), 177–184.PubMedCrossRefGoogle Scholar
  32. Hirvikoski, T., Waaler, E., Alfredsson, J., Pihlgren, C., Holmstrom, A., Johnson, A., et al. (2011). Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behavior Research and Therapy, 49(3), 175–185. doi:10.1016/j.brat.2011.01.001.CrossRefGoogle Scholar
  33. Jasinski, D. R., Faries, D. E., Moore, R. J., Schuh, L. M., & Allen, A. J. (2008). Abuse liability assessment of atomoxetine in a drug-abusing population. Drug and Alcohol Dependence, 95(1–2), 140–146.PubMedCrossRefGoogle Scholar
  34. Kalbag, A. S., & Levin, F. R. (2005). Adult ADHD and substance abuse: diagnostic and treatment issues. Substance Use & Misuse, 40(13–14), 1955–1981.CrossRefGoogle Scholar
  35. Katz, L. J., Wood, D. S., Goldstein, G., Auchenbach, R. C., & Geckle, M. (1998). The utility of neuropsychological tests in evaluation of Attention-Deficit/ Hyperactivity Disorder (ADHD) versus depression in adults. Assessment, 5(1), 45–52.PubMedCrossRefGoogle Scholar
  36. Kaye, S., Darke, S., & Torok, M. (2013). Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder? Addiction, 108(5), 923–931. doi:10.1111/add.12086.PubMedCrossRefGoogle Scholar
  37. Kendall, T., Taylor, E., Perez, A., Taylor, C., & THOMPSON, A. (2008). Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. Commentary. BMJ. British medical Journal, 337(7672), 751–754.Google Scholar
  38. Kim, E. Y., & Miklowitz, D. J. (2002). Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disorders, 4(4), 215–225.PubMedCrossRefGoogle Scholar
  39. Kleber, H. D., Weiss, R. D., Anton, R. F., Jr., George, T. P., Greenfield, S. F., Kosten, T. R., Regier, D. (2007). Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry, 164(4 Suppl), 5–123.Google Scholar
  40. Kollins, S. H. (2003). Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Journal of Clinical Psychiatry, 64, 14–18.PubMedCrossRefGoogle Scholar
  41. Kollins, S. H. (2008). ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. Journal of Attention Disorders, 12(2), 115–125. doi:10.1177/1087054707311654.PubMedCrossRefGoogle Scholar
  42. Konstenius, M., Jayaram-Lindstrom, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2013). Methylphenidate for ADHD and drug relapse in criminal offenders with substance dependence: A 24-week randomized placebo-controlled trial. Addiction. doi:10.1111/add.12369.PubMedCentralGoogle Scholar
  43. Kooij, J. S. (2012). Adult ADHD: Diagnostic assessment and treatment. London: Springer.Google Scholar
  44. Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., et al. (2010). European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry, 10(1), 67.PubMedCrossRefPubMedCentralGoogle Scholar
  45. Levin, F. R., & Upadhyaya, H. P. (2007). Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis. Journal of Clinical Psychiatry, 68(7), e18.PubMedCrossRefGoogle Scholar
  46. Levin, F. R., Evans, S. M., & Kleber, H. D. (1999). Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatric Services, 50(8), 1001–1003.PubMedGoogle Scholar
  47. Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002). Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. Journal of Addictive Diseases, 21(2), 1–16.PubMedCrossRefGoogle Scholar
  48. Levin, F. R., Evans, S. M., Vosburg, S. K., Horton, T., Brooks, D., & Ng, J. (2004). Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors, 29(9), 1875–1882.PubMedCrossRefGoogle Scholar
  49. Levin, F. R., Evans, S. M., Brooks, D. J., Kalbag, A. S., Garawi, F., & Nunes, E. V. (2006). Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug and Alcohol Dependence, 81(2), 137–148.PubMedCrossRefGoogle Scholar
  50. Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007). Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence, 87(1), 20–29.PubMedCrossRefGoogle Scholar
  51. Levin, F. R., Bisaga, A., Raby, W., Aharonovich, E., Rubin, E., Mariani, J., et al. (2008). Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment, 34(1), 80–89.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Levin, F. R., Mariani, J. J., Secora, A., Brooks, D., Cheng, W. Y., Bisaga, A., et al. (2009). Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial. Journal of Dual Diagnosis, 5(1), 41–56.PubMedCrossRefPubMedCentralGoogle Scholar
  53. Maidment, I. D. (2003). The use of antidepressants to treat attention deficit hyperactivity disorder in adults. Journal of Psychopharmacology, 17(3), 332–336.PubMedCrossRefGoogle Scholar
  54. Mann, N., & Bitsios, P. (2009). Modafinil treatment of amphetamine abuse in adult ADHD. Journal of Psychopharmacology, 23(4), 468–471.PubMedCrossRefGoogle Scholar
  55. Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co–occurring adhd and substance use disorders. The American Journal on Addictions, 16(s1), 45–56.PubMedCrossRefPubMedCentralGoogle Scholar
  56. Matthys, F., Joostens, P., Stes, S., Tremmery, S., & Sabbe, B. (2013). The construction of the first validated (evidence based) guideline for dual diagnosis of ADHD and SUD; data from focus groups. International Journal of Mental Health and Addiction, 11(5), 557–567. doi:10.1007/s11469-013-9438-1.CrossRefGoogle Scholar
  57. Mészáros, A., Czobor, P., Bálint, S., Komlósi, S., Simon, V., & Bitter, I. (2009). Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. The International Journal of Neuropsychopharmacology, 12(08), 1137–1147.PubMedCrossRefGoogle Scholar
  58. Monuteaux, M. C., Wilens, T. E., & Biederman, J. (2007). Does social class predict substance problems in young adults with ADHD? The American Journal on Addictions, 16(5), 403–409.PubMedCrossRefGoogle Scholar
  59. Murphy, K. (2005). Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. Journal of Clinical Psychology, 61(5), 607–619.PubMedCrossRefGoogle Scholar
  60. Peterson, K., McDonagh, M. S., & Fu, R. (2008). Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology, 197(1), 1–11.PubMedCrossRefGoogle Scholar
  61. Philipsen, A., Richter, H., Peters, J., Alm, B., Sobanski, E., Colla, M., et al. (2007). Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. The Journal of Nervous and Mental Disease, 195(12), 1013–1019.PubMedCrossRefGoogle Scholar
  62. Quinn, P. O. (2008). Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: an evolving picture. Current Psychiatry Reports, 10(5), 419–423.PubMedCrossRefGoogle Scholar
  63. Ramsay, J. R., & Rostain, A. L. (2005). Adapting psychotherapy to meet the needs of adults with attention-deficit/hyperactivity disorder. Psychotherapy: Theory, Research, Practice, Training, 42(1), 72–84.CrossRefGoogle Scholar
  64. Riggs, P. D., Leon, S. L., Mikulich, S. K., & Pottle, L. C. (1998). An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 37(12), 1271–1278.CrossRefGoogle Scholar
  65. Rigter, H. (2006). What drug policies cost: drug policy spending in the Netherlands in 2003. Addiction, 101(3), 323–329.PubMedCrossRefGoogle Scholar
  66. Robison, R. J., Reimherr, F. W., Marchant, B. K., Faraone, S. V., Adler, L. A., & West, S. A. (2008). Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. The Journal of Clinical Psychiatry, 69(2), 213–221.PubMedCrossRefGoogle Scholar
  67. Rohde, L. A., Szobot, C., Polanczyk, G., Schmitz, M., Martins, S., & Tramontina, S. (2005). Attention-deficit/hyperactivity disorder in a diverse culture: do research and clinical findings support the notion of a cultural construct for the disorder? Biological Psychiatry, 57(11), 1436–1441.PubMedCrossRefGoogle Scholar
  68. Rostain, A. L., & Ramsay, J. R. (2006). A combined treatment approach for adults with ADHD–results of an open study of 43 patients. Journal of Attention Disorders, 10(2), 150–159.PubMedCrossRefGoogle Scholar
  69. Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005). Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behavior Research and Therapy, 43(7), 831–842.CrossRefGoogle Scholar
  70. Safren, S. A., Sprich, S., Mimiaga, M. J., Surman, C., Knouse, L., Groves, M., et al. (2010). Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. Jama, 304(8), 875–880.PubMedCrossRefPubMedCentralGoogle Scholar
  71. Sign.ac.uk. (2001). Scottish intercollegiate guidelines network (SIGN). SIGN 50: A guideline developer’s handbook. Retrieved from: http://www.sign.ac.uk.
  72. Solanto, M. V., Marks, D. J., Mitchell, K. J., Wasserstein, J., & Kofman, M. D. (2008). Development of a new psychosocial treatment for adult ADHD. Journal of Attention Disorders, 11(6), 728–736.PubMedCrossRefGoogle Scholar
  73. Solanto, M. V., Marks, D. J., Wasserstein, J., Mitchell, K., Abikoff, H., Alvir, J. M., et al. (2010). Efficacy of meta-cognitive therapy for adult ADHD. American Journal of Psychiatry, 167(8), 958–968. doi:10.1176/appi.ajp.2009.09081123.PubMedCrossRefPubMedCentralGoogle Scholar
  74. Solhkhah, R., Wilens, T. E., Daly, J., Prince, J. B., Van Patten, S. L., & Biederman, J. (2005). Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. Journal of Child & Adolescent Psychopharmacology, 15(5), 777–786.CrossRefGoogle Scholar
  75. Somoza, E. C., Winhusen, T. M., Bridge, T. P., Rotrosen, J. P., Vanderburg, D. G., Harrer, J. M., et al. (2004). An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases, 23(1), 77–92.PubMedCrossRefGoogle Scholar
  76. Sullivan, M. A., & RUDNIK–LEVIN, F. R. A. N. C. E. S. (2001). Attention deficit/hyperactivity disorder and substance abuse. Annals of the New York Academy of Sciences, 931(1), 251–270.PubMedCrossRefGoogle Scholar
  77. Szobot, C. M., Shih, M. C., Schaefer, T., Júnior, N., Hoexter, M. Q., Fu, Y. K., et al. (2008). Methylphenidate DAT binding in adolescents with attention-deficit/hyperactivity disorder comorbid with substance use disorder-a single photon emission computed tomography with [Tc <sup> 99m</sup>] TRODAT-1 study. Neuroimage, 40(3), 1195–1201.PubMedCrossRefGoogle Scholar
  78. Thurstone, C., Riggs, P. D., Salomonsen-Sautel, S., & Mikulich-Gilbertson, S. K. (2010). Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 49(6), 573–582.Google Scholar
  79. Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004). Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry, 55(10), 1031–1040.PubMedCrossRefGoogle Scholar
  80. Upadhyaya, H. P. (2006). Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. The Journal of Clinical Psychiatry, 68, 23–30.Google Scholar
  81. Vaiva, G., De Lenclave, M. B., & Bailly, D. (2002). Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. Progress in Neuropsychopharmacology and Biological Psychiatry, 26(3), 609–611.CrossRefGoogle Scholar
  82. van de Glind, G., van den Brink, W., Koeter, M. W., Carpentier, P. J., van Emmerik-van Oortmerssen, K., Kaye, S., et al. (2013). Validity of the adult ADHD self-report scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence. doi:10.1016/j.drugalcdep.2013.04.010.Google Scholar
  83. van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., et al. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1–2), 11–19.PubMedCrossRefGoogle Scholar
  84. van Emmerik-van Oortmerssen, K., Vedel, E., Koeter, M. W., de Bruijn, K., Dekker, J. J. M., van den Brink, W. et al. (2013). Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry, 13. doi: 10.1186/1471-244x-13-132
  85. Verbeeck, W., Tuinier, S., & Bekkering, G. E. (2009). Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Advances in Therapy, 26(2), 170–184. doi:10.1007/s12325-009-0008-7.PubMedCrossRefGoogle Scholar
  86. Virta, M., Vedenpää, A., Grönroos, N., Chydenius, E., Partinen, M., Vataja, R., et al. (2008). Adults with ADHD benefit from cognitive—behaviorally oriented group rehabilitation a study of 29 participants. Journal of Attention Disorders, 12(3), 218–226.PubMedCrossRefGoogle Scholar
  87. Volkow, N. D., & Swanson, J. M. (2003). Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. American Journal of Psychiatry, 160(11), 1909–1918.PubMedCrossRefGoogle Scholar
  88. Waite, R. (2007). Women and attention deficit disorders: a great burden overlooked. Journal of the American Academy of Nurse Practitioners, 19(3), 116–125.PubMedCrossRefGoogle Scholar
  89. West, S. L., Mulsow, M., & Arredondo, R. (2003). Factor analysis of the attention deficit scales for adults (ADSA) with a clinical sample of outpatient substance abusers. The American Journal on Addictions, 12(2), 159–165.PubMedCrossRefGoogle Scholar
  90. West, S. L., Mulsow, M., & Arredondo, R. (2007). An examination of the psychometric properties of the attention deficit scales for adults with outpatient substance abusers. The American Journal of Drug and Alcohol Abuse, 33(5), 755–764.PubMedCrossRefGoogle Scholar
  91. Wilens, T. E. (2004a). Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America, 27(2), 283–301.PubMedCrossRefGoogle Scholar
  92. Wilens, T. E. (2004b). Impact of ADHD and its treatment on substance abuse in adults. Journal of Clinical Psychiatry, 65(Suppl 3), 38–45.PubMedGoogle Scholar
  93. Wilens, T. E., & Upadhyaya, H. P. (2007). Impact of substance use disorder on ADHD and its treatment. The Journal of Clinical Psychiatry, 68(8), e20.PubMedCrossRefGoogle Scholar
  94. Wilens, T. E., Biederman, J., Mick, E., Faraone, S. V., & Spencer, T. (1997). Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. The Journal of Nervous & Mental Disease, 185(8), 475–482.CrossRefGoogle Scholar
  95. Wilens, T. E., Kwon, A., Tanguay, S., Chase, R., Moore, H., Faraone, S. V., et al. (2005). Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. The American Journal on Addictions, 14(4), 319–327.PubMedCrossRefGoogle Scholar
  96. Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J., et al. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug & Alcohol Dependence, 96(1–2), 145–154.CrossRefGoogle Scholar
  97. Wilens, T. E., Prince, J. B., Waxmonsky, J., Doyle, R., Spencer, T., Martelon, M., et al. (2010). An open trial of sustained release bupropion for attention-deficit/hyperactivity disorder in adults with ADHD plus substance use disorders. Journal of ADHD & related disorders, 1(3), 25–35.Google Scholar
  98. Wilens, T. E., Adler, L. A., Tanaka, Y., Xiao, F., D’Souza, D. N., Gutkin, S. W., et al. (2011). Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Current Medical Research & Opinion, 27(12), 2309–2320. doi:10.1185/03007995.2011.628648.CrossRefGoogle Scholar
  99. Wilson, J. J. (2007). ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment. The American Journal on Addictions, 16(s1), 5–13.PubMedCrossRefGoogle Scholar
  100. Wilson, J. J., & Levin, F. R. (2001). Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Current Psychiatry Reports, 3(6), 497–506.PubMedCrossRefGoogle Scholar
  101. Winhusen, T., Somoza, E., Singal, B. M., Harrer, J., Apparaju, S., Mezinskis, J., et al. (2006). Methylphenidate and cocaine: a placebo-controlled drug interaction study. Pharmacology Biochemistry and Behavior, 85(1), 29–38.CrossRefGoogle Scholar
  102. Zylowska, L., Ackerman, D. L., Yang, M. H., Futrell, J. L., Horton, N. L., Hale, T. S., et al. (2008). Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. Journal of Attention Disorders, 11(6), 737–746.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Frieda Matthys
    • 1
  • Steven Stes
    • 2
  • Wim van den Brink
    • 3
  • Peter Joostens
    • 4
  • David Möbius
    • 5
  • Sabine Tremmery
    • 6
    • 7
  • Bernard Sabbe
    • 8
  1. 1.University Hospital Brussels and Free University Brussels (VUB), MSOC Free ClinicAntwerpBelgium
  2. 2.University Psychiatric Centre at Katholieke Universiteit LeuvenLeuvenBelgium
  3. 3.Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  4. 4.Psychiatric Centre Broeders AlexianenTienenBelgium
  5. 5.Vereniging voor Alcohol- en andere DrugproblemenBrusselsBelgium
  6. 6.Department Child & Adolescent PsychiatryUniversity Hospitals LeuvenLeuvenBelgium
  7. 7.Department of NeurosciencesKU LeuvenLeuvenBelgium
  8. 8.Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Free University Brussels (VUB) and Psychiatric Hospital Sint-NorbertusDuffelBelgium

Personalised recommendations